Published in J Proteome Res on December 01, 2008
A gene-centric human proteome project: HUPO--the Human Proteome organization. Mol Cell Proteomics (2010) 3.05
Antibody-based protein profiling of the human chromosome 21. Mol Cell Proteomics (2011) 0.82
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels. J Clin Bioinforma (2011) 0.82
The Moscow HUPO Human Proteome Project workshop. Mol Cell Proteomics (2009) 0.75
Functional proteomic analysis of human nucleolus. Mol Biol Cell (2002) 3.07
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One (2012) 1.76
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol (2006) 1.25
EasyProt--an easy-to-use graphical platform for proteomics data analysis. J Proteomics (2012) 1.20
How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res (2007) 1.11
Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis (2002) 0.97
Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem (2008) 0.97
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2010) 0.97
Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics (2004) 0.96
The human proteome project: Current state and future direction. Mol Cell Proteomics (2011) 0.96
Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. Clin Chem Lab Med (2013) 0.91
Is a gene-centric human proteome project the best way for proteomics to serve biology? Proteomics (2010) 0.90
Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J (2006) 0.87
Proteomic approaches to study Staphylococcus aureus pathogenesis. J Proteomics (2009) 0.87
Multi-dimensional HPLC/MS of the nucleolar proteome using HPLC-chip/MS. J Sep Sci (2006) 0.84
Proteomic approach to investigate MRSA. Methods Mol Biol (2007) 0.84
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers. Drug Metab Lett (2008) 0.81
Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique. Clin Biochem (2008) 0.81
Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes. Transpl Int (2002) 0.81
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Arthritis Care Res (Hoboken) (2012) 0.80
Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.80
Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism. Thromb Haemost (2009) 0.78
Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. Anal Bioanal Chem (2011) 0.77
[From genome to proteome--aim of human proteomics]. Seikagaku (2004) 0.77
LC-MS (/MS) in clinical toxicology screening methods. Chimia (Aarau) (2012) 0.77
Identification of hemoglobin variants by top-down mass spectrometry using selected diagnostic product ions. Anal Bioanal Chem (2015) 0.77
Urinary proteomics and drug discovery in chronic kidney disease: a new perspective. J Proteome Res (2010) 0.77
Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res (2007) 0.77
Proteomic approach to investigate pathogenicity and metabolism of methicillin-resistant Staphylococcus aureus. Methods Mol Biol (2014) 0.76
Quantitative mass spectrometry analysis of intact hemoglobin A2 by precursor ion isolation and detection. Anal Chem (2013) 0.76
Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro. Eur J Pharm Biopharm (2008) 0.76
Qualitative and quantitative analysis of glycated proteins in human plasma by glucose isotopic labeling with ¹³C6-reducing sugars. Methods Mol Biol (2011) 0.76
Translational proteomics. J Proteomics (2012) 0.75
Mass spectrometry in laboratory medicine. Clin Chem Lab Med (2003) 0.75
The magic of words. J Proteomics (2014) 0.75
Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods. Clin Chem Lab Med (2011) 0.75
The 9th Siena Meeting - from genome to proteome: open innovations. J Proteomics (2013) 0.75
Extraction of amino acids by reverse iontophoresis in vivo. Eur J Pharm Biopharm (2009) 0.75
Detection of biomarkers of stroke using SELDI-TOF. Methods Mol Biol (2007) 0.75